Search research articles
Contact Us
Filters
Showing results (271-280 of 281) with videos related to
Page
of 29
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
March 3, 2018
Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience
C M Mak, S Pl Chen, N S Mok, et al.
The New England Journal of Medicine
|
June 14, 2013
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma
Kol Jia Yong, Chong Gao, Joline S J Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen
Andrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 22, 2013
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
Joong-Won Park, Deepak Amarapurkar, Yee Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study
Josep M Llovet, Thomas Decaens, Jean-Luc Raoul, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
Andrew M Scott, Fook-Thean Lee, Niall Tebbutt, et al.
Journal of Sport and Health Science
|
November 22, 2024
The Youth Fitness International Test (YFIT) battery for monitoring and surveillance among children and adolescents: A modified Delphi consensus project with 169 experts from 50 countries and territories
Francisco B Ortega, Kai Zhang, Cristina Cadenas-Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2014
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma
Darrell R Borger, Lipika Goyal, Thomas Yau, et al.
Nature Genetics
|
May 29, 2012
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Wing-Kin Sung, Hancheng Zheng, Shuyu Li, et al.
Annals of Surgery
|
November 17, 2009
The international position on laparoscopic liver surgery: The Louisville Statement, 2008
Joseph F Buell, Daniel Cherqui, David A Geller, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 281) with videos related to
Sort By:
Page
of 29
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
March 3, 2018
Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience
C M Mak, S Pl Chen, N S Mok, et al.
The New England Journal of Medicine
|
June 14, 2013
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma
Kol Jia Yong, Chong Gao, Joline S J Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2007
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen
Andrew M Scott, Niall Tebbutt, Fook-Thean Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 22, 2013
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
Joong-Won Park, Deepak Amarapurkar, Yee Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2013
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study
Josep M Llovet, Thomas Decaens, Jean-Luc Raoul, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2007
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
Andrew M Scott, Fook-Thean Lee, Niall Tebbutt, et al.
Journal of Sport and Health Science
|
November 22, 2024
The Youth Fitness International Test (YFIT) battery for monitoring and surveillance among children and adolescents: A modified Delphi consensus project with 169 experts from 50 countries and territories
Francisco B Ortega, Kai Zhang, Cristina Cadenas-Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2014
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma
Darrell R Borger, Lipika Goyal, Thomas Yau, et al.
Nature Genetics
|
May 29, 2012
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Wing-Kin Sung, Hancheng Zheng, Shuyu Li, et al.
Annals of Surgery
|
November 17, 2009
The international position on laparoscopic liver surgery: The Louisville Statement, 2008
Joseph F Buell, Daniel Cherqui, David A Geller, et al.
Page
of 29